Evaluating the Efficacy of Therapies in Patients With Coronavirus Disease 2019

There is a proliferation of clinical trials worldwide to find effective therapies for patients diagnosed with coronavirus disease 2019 (COVID-19). The endpoints that are currently used to evaluate the efficacy of therapeutic agents against COVID-19 are focused on clinical status at a particular day...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dan-Yu, Zeng, Donglin, Eron, Joseph J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Invited Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454372/
https://www.ncbi.nlm.nih.gov/pubmed/32818962
http://dx.doi.org/10.1093/cid/ciaa1231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454372/
https://www.ncbi.nlm.nih.gov/pubmed/32818962
http://dx.doi.org/10.1093/cid/ciaa1231

Ejemplares similares